Source link : https://newshealth.biz/health-news/novel-oral-agent-proves-mettle-in-obstructive-hypertrophic-cardiomyopathy/
(MedPage Today) — MADRID — The novel oral cardiac myosin inhibitor aficamten improved exercise capacity and symptoms of obstructive hypertrophic cardiomyopathy (HCM) better than standard beta-blocker treatment, the MAPLE-HCM randomized trial… Source link : https://www.medpagetoday.com/meetingcoverage/esc/117221 Author : Publish date : 2025-08-30 07:18:00 Copyright for syndicated content belongs to the linked Source.
The post Novel Oral Agent Proves Mettle in Obstructive Hypertrophic Cardiomyopathy first appeared on News Health.
—-
Author : News Health
Publish date : 2025-08-30 07:18:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8